24 results on '"Karnasuta, Chitraporn"'
Search Results
2. Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials
3. Safety and Immunogenicity of an HIV Subtype B and E Prime-Boost Vaccine Combination in HIV-Negative Thai Adults
4. Immune Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
5. Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I /II ALVAC-HIV /AIDSVAX ® B/E prime-boost HIV-1 vaccine trial in Thailand
6. Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults
7. Comparison of Antibody Responses Induced by RV144, VAX003, and VAX004 Vaccination Regimens
8. Characterization of HIV-1 gp120 antibody specificities induced in anogenital secretions of RV144 vaccine recipients after late boost immunizations.
9. IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens.
10. HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX® B/E
11. 167 Magnitude and Breadth of the Neutralizing Antibody Response in RV144
12. Induction of HIV-specific functional immune responses by a multiclade HIV-1 DNA vaccine candidate in healthy Ugandans
13. A Phase 1/2 Comparative Vaccine Trial of the Safety and Immunogenicity of a CRF01_AE (Subtype E) Candidate Vaccine
14. Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX® B/E prime-boost HIV-1 vaccine trial in Thailand
15. Distinguishing Plasmodium falciparum Treatment Failures from Reinfections by Restriction Fragment Length Polymorphism and Polymerase Chain Reaction Genotyping
16. Enhanced detection of Plasmodium vivax liver stages by cytocentrifugation
17. Complete Development of the Liver Stage of Plasmodium falciparum in a Human Hepatoma Cell Line
18. Efficacy and Tolerance of Extended-Dose Halofantrine for Drug-Resistant Falciparum Malaria in Thailand
19. A Phase 1/2 Comparative Vaccine Trial of the Safety and Immunogenicity of a CRFO1-AE (Subtype E) Candidate Vaccine: ALVAC-HIV (vCP1521) Prime With Oligomeric gp16O (92TH023/LAI-DID) or Bivalent gp12O (CM235/SF2) Boost.
20. Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX® B/E prime-boost HIV-1 vaccine trial in Thailand
21. Enhanced Sensitivity of Detection of Cytotoxic T Lymphocyte Responses to HIV Type 1 Proteins Using an Extended In Vitro Stimulation Period for Measuring Effector Function in Volunteers Enrolled in an ALVAC-HIV Phase I/II Prime Boost Vaccine Trial in Thailand
22. HIV-specific Antibody in Rectal Secretions Following Late Boosts in RV144 Participants (RV305).
23. HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX® B/E
24. Randomized, Double-Blind Evaluation of Late Boost Strategies for HIV-Uninfected Vaccine Recipients in the RV144 HIV Vaccine Efficacy Trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.